{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:06:36Z","timestamp":1788581196999,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["20720252004"],"award-info":[{"award-number":["20720252004"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371419"],"award-info":[{"award-number":["82371419"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025J01024"],"award-info":[{"award-number":["2025J01024"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016808","name":"Natural Science Foundation of Xiamen Municipality","doi-asserted-by":"publisher","award":["3502Z202373014"],"award-info":[{"award-number":["3502Z202373014"]}],"id":[{"id":"10.13039\/100016808","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.phrs.2026.108265","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:09:19Z","timestamp":1779984559000},"page":"108265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Ext1-targeted gene therapy ameliorates tauopathy by inhibiting heparan sulfate-dependent tau propagation"],"prefix":"10.1016","volume":"230","author":[{"given":"Rongyao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1790-3647","authenticated-orcid":false,"given":"Chunyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8473-0294","authenticated-orcid":false,"given":"Jinghan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naizhen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108265_bib1","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108265_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-022-00533-z","article-title":"Tauopathies: new perspectives and challenges","volume":"17","author":"Zhang","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"12","key":"10.1016\/j.phrs.2026.108265_bib3","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168553","article-title":"Tau pathology in neurodegenerative disease: disease mechanisms and therapeutic avenues","volume":"133","author":"Samudra","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.phrs.2026.108265_bib4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41580-024-00753-9","article-title":"Cellular and pathological functions of tau","volume":"25","author":"Parra Bravo","year":"2024","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108265_bib5","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004952","article-title":"Heparan sulfate proteoglycans","volume":"3","author":"Sarrazin","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"332","key":"10.1016\/j.phrs.2026.108265_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad3650","article-title":"Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-beta clearance and aggregation in Alzheimer's disease","volume":"8","author":"Liu","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.phrs.2026.108265_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/biom12121792","article-title":"Heparan Sulfate Proteoglycans in Tauopathy","volume":"12","author":"Zhu","year":"2022","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.phrs.2026.108265_bib8","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0002-9440(10)65529-0","article-title":"Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain","volume":"155","author":"Verbeek","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108265_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ajmg.b.30015","article-title":"An association study of a polymorphism in the heparan sulfate proteoglycan gene (perlecan, HSPG2) and Alzheimer's disease","volume":"128B","author":"Rosenmann","year":"2004","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2026.108265_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53038-z","article-title":"Contribution of syndecans to cellular uptake and fibrillation of alpha-synuclein and tau","volume":"9","author":"Hudak","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.phrs.2026.108265_bib11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s004010051034","article-title":"Microtubule-associated protein tau, heparan sulphate and alpha-synuclein in several neurodegenerative diseases with dementia","volume":"97","author":"Spillantini","year":"1999","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108265_bib12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0306-4522(92)90521-3","article-title":"Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease","volume":"51","author":"Su","year":"1992","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.phrs.2026.108265_bib13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/BF00309625","article-title":"Pick's disease immunohistochemistry: new alterations and Alzheimer's disease comparisons","volume":"89","author":"Yasuhara","year":"1995","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108265_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jocn.2008.04.009","article-title":"Interaction between beta-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer's disease","volume":"16","author":"Shimizu","year":"2009","journal-title":"J. Clin. Neurosci."},{"issue":"41","key":"10.1016\/j.phrs.2026.108265_bib15","doi-asserted-by":"crossref","first-page":"26265","DOI":"10.1074\/jbc.273.41.26265","article-title":"The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate","volume":"273","author":"Lind","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"45","key":"10.1016\/j.phrs.2026.108265_bib16","doi-asserted-by":"crossref","first-page":"32802","DOI":"10.1074\/jbc.M703560200","article-title":"Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation","volume":"282","author":"Busse","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2026.108265_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/dbio.2000.9798","article-title":"Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice","volume":"224","author":"Lin","year":"2000","journal-title":"Dev. Biol."},{"issue":"27","key":"10.1016\/j.phrs.2026.108265_bib18","doi-asserted-by":"crossref","first-page":"10826","DOI":"10.1074\/jbc.RA117.000378","article-title":"Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau versus alpha-synuclein and beta-amyloid aggregates","volume":"293","author":"Stopschinski","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2026.108265_bib19","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1038\/s41598-018-24904-z","article-title":"Tau Internalization is Regulated by 6-O Sulfation on Heparan Sulfate Proteoglycans (HSPGs)","volume":"8","author":"Rauch","year":"2018","journal-title":"Sci. Rep."},{"issue":"33","key":"10.1016\/j.phrs.2026.108265_bib20","doi-asserted-by":"crossref","first-page":"E3138","DOI":"10.1073\/pnas.1301440110","article-title":"Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds","volume":"110","author":"Holmes","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"13","key":"10.1016\/j.phrs.2026.108265_bib21","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1073\/pnas.1117881109","article-title":"Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate","volume":"109","author":"Irie","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.phrs.2026.108265_bib22","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1038\/s41467-025-57163-4","article-title":"Heparan sulfate regulates myofibroblast heterogeneity and function to mediate niche homeostasis during alveolar morphogenesis","volume":"16","author":"He","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2026.108265_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12974-020-01749-w","article-title":"The behavioural and neuropathologic sexual dimorphism and absence of MIP-3alpha in tau P301S mouse model of Alzheimer's disease","volume":"17","author":"Sun","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2026.108265_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-015-0001-3","article-title":"Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Abeta metabolism in apoE4-targeted replacement mice","volume":"10","author":"Hu","year":"2015","journal-title":"Mol. Neurodegener."},{"issue":"12","key":"10.1016\/j.phrs.2026.108265_bib25","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41593-022-01191-6","article-title":"Bassoon contributes to tau-seed propagation and neurotoxicity","volume":"25","author":"Martinez","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2026.108265_bib26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s13311-013-0194-5","article-title":"Antisense oligonucleotides: treating neurodegeneration at the level of RNA","volume":"10","author":"DeVos","year":"2013","journal-title":"Neurotherapeutics"},{"issue":"19","key":"10.1016\/j.phrs.2026.108265_bib27","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1016\/j.neuron.2024.07.013","article-title":"Antisense oligonucleotides enhance SLC20A2 expression and suppress brain calcification in a humanized mouse model","volume":"112","author":"Zhao","year":"2024","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.phrs.2026.108265_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm.4011","article-title":"Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling","volume":"22","author":"Myeku","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2026.108265_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.1050768","article-title":"Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer's disease and tauopathy models","volume":"9","author":"Selvarasu","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"10","key":"10.1016\/j.phrs.2026.108265_bib30","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.neuron.2024.02.017","article-title":"P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy","volume":"112","author":"Zhang","year":"2024","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.phrs.2026.108265_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neuron.2022.10.021","article-title":"Microglial Piezo1 senses Abeta fibril stiffness to restrict Alzheimer's disease","volume":"111","author":"Hu","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2026.108265_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/978-1-4939-3271-9_17","article-title":"Widespread Neuronal Transduction of the Rodent CNS via Neonatal Viral Injection","volume":"1382","author":"Kim","year":"2016","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108265_bib33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s12264-022-00974-y","article-title":"Extension of the Lifespan of a Mouse Model of Rett Syndrome by Intracerebroventricular Delivery of MECP2","volume":"39","author":"Yang","year":"2023","journal-title":"Neurosci. Bull."},{"issue":"1","key":"10.1016\/j.phrs.2026.108265_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41593-024-01838-6","article-title":"An RNA editing strategy rescues gene duplication in a mouse model of MECP2 duplication syndrome and nonhuman primates","volume":"28","author":"Yang","year":"2025","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2026.108265_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41593-024-01829-7","article-title":"vivo hyperphosphorylation of tau is associated with synaptic loss and behavioral abnormalities in the absence of tau seeds","volume":"28","author":"Watamura","year":"2025","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108265_bib36","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.1038\/s41467-025-61497-4","article-title":"Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer's disease","volume":"16","author":"Luan","year":"2025","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.phrs.2026.108265_bib37","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/alz.12097","article-title":"vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET","volume":"16","author":"Mecca","year":"2020","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.phrs.2026.108265_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2026.108265_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.671458","article-title":"The Sulfation Code of Tauopathies: Heparan Sulfate Proteoglycans in the Prion Like Spread of Tau Pathology","volume":"8","author":"Mah","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"6","key":"10.1016\/j.phrs.2026.108265_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw6404","article-title":"Experimental evidence for the age dependence of tau protein spread in the brain","volume":"5","author":"Wegmann","year":"2019","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.phrs.2026.108265_bib41","article-title":"Hippocampal - diencephalic - cingulate networks for memory and emotion: An anatomical guide","volume":"1","author":"Bubb","year":"2017","journal-title":"Brain Neurosci. Adv."},{"issue":"4","key":"10.1016\/j.phrs.2026.108265_bib42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","article-title":"Propagation of tau pathology in a model of early Alzheimer's disease","volume":"73","author":"de Calignon","year":"2012","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.phrs.2026.108265_bib43","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","article-title":"Antisense technology: an overview and prospectus","volume":"20","author":"Crooke","year":"2021","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.phrs.2026.108265_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100416","article-title":"Antisense technology: A review","volume":"296","author":"Crooke","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.phrs.2026.108265_bib45","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.neuron.2017.04.010","article-title":"Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases","volume":"94","author":"Schoch","year":"2017","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.phrs.2026.108265_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","article-title":"Antisense oligonucleotides: the next frontier for treatment of neurological disorders","volume":"14","author":"Rinaldi","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2026.108265_bib47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-neuro-070918-050501","article-title":"Antisense Oligonucleotide Therapies for Neurodegenerative Diseases","volume":"42","author":"Bennett","year":"2019","journal-title":"Annu. Rev. Neurosci."},{"issue":"374","key":"10.1016\/j.phrs.2026.108265_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.phrs.2026.108265_bib49","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/nar\/gkaa1235","article-title":"The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administration","volume":"49","author":"Jafar-Nejad","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2026.108265_bib50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neurobiolaging.2021.09.006","article-title":"Pathological tau and reactive astrogliosis are associated with distinct functional deficits in a mouse model of tauopathy","volume":"109","author":"Patel","year":"2022","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.phrs.2026.108265_bib51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"613","key":"10.1016\/j.phrs.2026.108265_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg9922","article-title":"Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury","volume":"13","author":"Graham","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.phrs.2026.108265_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115382","article-title":"Secreted neurofilament light chain after neuronal damage induces myeloid cell activation and neuroinflammation","volume":"44","author":"Kahn","year":"2025","journal-title":"Cell. Rep."},{"issue":"5","key":"10.1016\/j.phrs.2026.108265_bib54","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/anie.201913029","article-title":"3-O-sulfation of heparan sulfate enhances tau interaction and cellular uptake","volume":"59","author":"Zhao","year":"2020","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"41","key":"10.1016\/j.phrs.2026.108265_bib55","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1021\/acs.biochem.0c00443","article-title":"Aggregation kinetics and filament structure of a tau fragment are influenced by the sulfation pattern of the cofactor heparin","volume":"59","author":"Townsend","year":"2020","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.phrs.2026.108265_bib56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12860-022-00462-1","article-title":"The 3-O sulfation of heparan sulfate proteoglycans contributes to the cellular internalization of tau aggregates","volume":"23","author":"Ferreira","year":"2022","journal-title":"BMC Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108265_bib57","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13024-024-00786-w","article-title":"Distinct regulation of Tau Monomer and aggregate uptake and intracellular accumulation in human neurons","volume":"19","author":"Marvian","year":"2024","journal-title":"Mol. Neurodegener."},{"issue":"7","key":"10.1016\/j.phrs.2026.108265_bib58","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.celrep.2018.04.056","article-title":"Unconventional Secretion Mediates the Trans-cellular Spreading of Tau","volume":"23","author":"Katsinelos","year":"2018","journal-title":"Cell. Rep."},{"issue":"21","key":"10.1016\/j.phrs.2026.108265_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf6232","article-title":"Increased 3-O-sulfated heparan sulfate in Alzheimer's disease brain is associated with genetic risk gene HS3ST1","volume":"9","author":"Wang","year":"2023","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.phrs.2026.108265_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70396","article-title":"ApoE3 Christchurch and tau interaction as a protective mechanism against Alzheimer's disease","volume":"21","author":"Perez-Corredor","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"11","key":"10.1016\/j.phrs.2026.108265_bib61","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","article-title":"Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report","volume":"25","author":"Arboleda-Velasquez","year":"2019","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.phrs.2026.108265_bib62","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.neuron.2024.12.015","article-title":"ApoE3 R136S binds to Tau and blocks its propagation, suppressing neurodegeneration in mice with Alzheimer's disease","volume":"113","author":"Chen","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2026.108265_bib63","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3389\/fnins.2019.00442","article-title":"Extracellular monomeric tau is internalized by astrocytes","volume":"13","author":"Perea","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.phrs.2026.108265_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.645233","article-title":"Astrocytic propagation of tau in the context of Alzheimer's disease","volume":"15","author":"Fleeman","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"9","key":"10.1016\/j.phrs.2026.108265_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70589","article-title":"Protective mechanisms against Alzheimer's disease in APOE3-Christchurch homozygous astrocytes","volume":"21","author":"Tian","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.phrs.2026.108265_bib66","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/s41467-022-29552-6","article-title":"Microglial NF-kappaB drives tau spreading and toxicity in a mouse model of tauopathy","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.phrs.2026.108265_bib67","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nn.4132","article-title":"Depletion of microglia and inhibition of exosome synthesis halt tau propagation","volume":"18","author":"Asai","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2026.108265_bib68","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2023.11.029","article-title":"APOE3ch alters microglial response and suppresses Abeta-induced tau seeding and spread","volume":"187","author":"Chen","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2026.108265_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2024.103936","article-title":"Heparan sulfate proteoglycans: Mediators of cellular and molecular Alzheimer's disease pathogenic factors via tunnelling nanotubes?","volume":"129","author":"Nguyen","year":"2024","journal-title":"Mol. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.phrs.2026.108265_bib70","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"issue":"18","key":"10.1016\/j.phrs.2026.108265_bib71","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"E.S. Group, Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.phrs.2026.108265_bib72","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Valor, O.L.E.W. Group, Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N. Engl. J. Med."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826001805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826001805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T14:05:33Z","timestamp":1785074733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826001805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":72,"alternative-id":["S1043661826001805"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108265","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ext1-targeted gene therapy ameliorates tauopathy by inhibiting heparan sulfate-dependent tau propagation","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108265"}}